Cai Lay Veterinary Pharmaceutical JSC

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000MKV4
VND
17,700.00
8000 (82.47%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
36,025.10
39,470.39
42,159.75
33,826.42
33,412.39
27,687.82
30,767.20
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
36,025.10
39,470.39
42,159.75
33,826.42
33,412.39
27,687.82
30,767.20
Raw Material Cost
25,241.50
23,418.96
27,543.13
22,521.81
23,781.38
18,018.41
18,820.05
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
7,081.83
0.00
5,903.19
4,878.58
5,770.73
5,865.66
3,927.03
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
5.41
Selling and Distribution Expenses
9,165.92
6,658.34
6,462.34
7,533.52
6,588.17
8,340.80
8,941.06
Other Expenses
-708.18
0.00
-590.32
-487.86
-577.07
-586.57
-393.24
Total Expenditure (Excl Depreciation)
34,407.41
30,077.30
34,005.48
30,055.33
30,369.55
26,359.22
27,761.11
Operating Profit (PBDIT) excl Other Income
1617.7
9393.099999999999
8154.299999999999
3771.1000000000004
3042.7999999999997
1328.6000000000001
3006.1000000000004
Other Income
-271.64
-661.83
-1,042.41
-934.61
-582.82
-972.49
-689.38
Operating Profit (PBDIT)
2,388.23
9,796.28
8,359.28
3,880.30
3,490.99
1,397.84
3,358.43
Interest
0.00
0.00
0.00
0.00
0.00
0.00
5.41
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
10,783.60
16,051.42
14,616.62
11,304.60
9,631.01
9,669.40
11,947.15
Depreciation
1,074.51
1,065.03
1,247.41
1,043.82
1,043.41
1,041.72
1,041.72
Profit Before Tax
1,313.72
8,731.26
7,111.86
2,836.47
2,447.58
356.11
2,311.29
Tax
265.00
1,746.84
1,422.37
567.31
489.70
102.38
463.97
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,048.72
6,984.42
5,689.49
2,269.16
1,957.88
253.74
1,847.32
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,048.72
6,984.42
5,689.49
2,269.16
1,957.88
253.74
1,847.32
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,048.72
6,984.42
5,689.49
2,269.16
1,957.88
253.74
1,847.32
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
Reserves
1,05,084.91
1,04,036.19
97,062.45
91,372.96
89,103.80
87,145.93
86,949.61
Earnings per share (EPS)
209.74
1396.88
1137.9
453.83
391.58
50.75
369.46
Diluted Earnings per share
209.74
1396.88
1137.9
453.83
391.58
50.75
369.46
Operating Profit Margin (Excl OI)
4.4%
23.8%
19.34%
11.15%
9.07%
4.8%
9.77%
Gross Profit Margin
6.63%
24.82%
19.83%
11.47%
10.45%
5.05%
10.9%
PAT Margin
2.91%
17.7%
13.5%
6.71%
5.86%
0.92%
6.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -8.73% vs -6.38% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is -84.99% vs 22.76% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -74.57% vs 11.24% in Dec 2025

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of Cai Lay Veterinary Pharmaceutical JSC With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Net Sales
36,025.10
46,007.49
-9,982.39
-21.70%
Other Operating Income
0.00
0.00
0.00
Total Operating income
36,025.10
46,007.49
-9,982.39
-21.70%
Raw Material Cost
25,241.50
32,497.42
-7,255.92
-22.33%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
7,081.83
0.00
7,081.83
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
1,326.42
-1,326.42
-100.00%
Selling and Distribution Expenses
9,165.92
8,012.38
1,153.54
14.40%
Other Expenses
-708.18
-132.64
-575.54
-433.91%
Total Expenditure (Excl Depreciation)
34,407.41
40,509.79
-6,102.38
-15.06%
Operating Profit (PBDIT) excl Other Income
1,617.68
5,497.70
-3,880.02
-70.58%
Other Income
-271.64
3.28
-274.92
-8,381.71%
Operating Profit (PBDIT)
2,388.23
10,984.91
-8,596.68
-78.26%
Interest
0.00
1,326.42
-1,326.42
-100.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
10,783.60
13,510.07
-2,726.47
-20.18%
Depreciation
1,074.51
5,483.92
-4,409.41
-80.41%
Profit Before Tax
1,313.72
4,174.57
-2,860.85
-68.53%
Tax
265.00
958.35
-693.35
-72.35%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,048.72
3,216.22
-2,167.50
-67.39%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,048.72
3,216.22
-2,167.50
-67.39%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,048.72
3,216.22
-2,167.50
-67.39%
Equity Capital
0
0
0.00
Face Value
10,000.00
10,000.00
0.00
Reserves
1,05,084.91
7,98,389.20
-6,93,304.29
-86.84%
Earnings per share (EPS)
209.74
233.57
-23.83
-10.20%
Diluted Earnings per share
209.74
233.57
-23.83
-10.20%
Operating Profit Margin (Excl OI)
4.40%
11.95%
0.00
-7.55%
Gross Profit Margin
6.63%
20.99%
0.00
-14.36%
PAT Margin
2.91%
6.99%
0.00
-4.08%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 3,602.51 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -8.73% vs -6.38% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 7.82% vs 38.39% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 104.87 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -84.99% vs 22.76% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -46.44% vs 10.20% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 265.99 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -74.57% vs 11.24% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -34.71% vs 4.46% in Mar 2025

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.40%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025